For more on this combination, see our cagrilintide and retatrutide dosing guide
Key injection site management strategies include: Rotating injection sites systematically for example, alternating between the abdomen, thigh, and upper arm to prevent repeated trauma to the same area Allowing the medication to reach room temperature before injection, in accordance with the product's storage instructions, as cold solutions can increase discomfort and local tissue irritation Using a new needle for each injection to maintain sharpness and reduce tissue damage Applying gentle pressure (but not rubbing) to the injection site after administration to minimise bruising Keeping the skin clean and dry around injection sites to reduce the risk of secondary infection Avoiding injection into broken, irritated, or infected skin For mild pruritus or erythema at the injection site, a cool compress applied for a few minutes post-injection can provide symptomatic relief
The standard dose escalation protocol Based on the Phase 2 clinical trial data published in the New England Journal of Medicine, the typical retatrutide dose schedule follows a pattern like this: During the starting phase, a single 10mg vial reconstituted with 2mL of bacteriostatic water can last up to 10 weeks at a 1mg weekly dose
The FDA has documented cases in which patients measuring compounded injectable semaglutide at home administered incorrect doses - some requiring hospitalization - due to concentration differences and unit conversion confusion
Persistently heavy bleeding (more than 80 mL per cycle, soaking through a pad or tampon hourly) should be evaluated regardless of GLP-1 use
Wipe down the rubber stoppers on both the peptide vial and the bacteriostatic water vial with an alcohol prep pad
